Sinopharm Group Co Ltd
F:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
A
|
Asia Plus Group Holdings PCL
SET:ASP
|
TH |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
A
|
Aristocrat Leisure Ltd
XMUN:AC8
|
AU |
Intrinsic Value
Is X2S undervalued or overvalued?
See the intrinsic value estimate for 
Sinopharm Group Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
X2S looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with X2S’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sinopharm Group Does
Sinopharm Group is one of China’s biggest drug distributors and pharmacy operators. It buys medicines, vaccines, medical devices, and healthcare products from manufacturers, then moves them through its own wholesale and retail network to hospitals, clinics, pharmacies, and other healthcare buyers. It also sells over-the-counter products and runs pharmacy stores under its own retail banners.
- Headquarters
- China CN
- Employees
- 94 910
- IPO date
- Sep 23, 2009
Sinopharm Group has no economic moat
Sinopharm Group Co Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Sinopharm Group Co Ltd
The intrinsic value for Sinopharm Group Co Ltd (X2S) under the Base Case is hidden EUR.
Compared with the current market price of 1.7875 EUR, the stock appears hidden.